BIRC5 and hepatocellular carcinoma: BIRC5 has been described as a negativeregulator of apoptosis, and its expression was reported to be higher in most tumorsincluding HCC [33–36],which is consistent with our findings indicating that the expression of BIRC5 ishigher in the high-risk group of HCC prognosis.